4//SEC Filing
Norkunas Matthew 4
Accession 0001415889-24-025336
CIK 0001733294other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:05 PM ET
Size
14.0 KB
Accession
0001415889-24-025336
Insider Transaction Report
Form 4
Norkunas Matthew
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-10-15−1,673→ 1,673 total→ Common Stock (1,673 underlying) - Exercise/Conversion
Common Stock
2024-10-15+1,674→ 56,659 total - Tax Payment
Common Stock
2024-10-15$2.42/sh−492$1,191→ 56,167 total - Exercise/Conversion
Common Stock
2024-10-15+1,673→ 57,840 total - Tax Payment
Common Stock
2024-10-15$2.42/sh−492$1,191→ 57,348 total - Exercise/Conversion
Restricted Stock Units
2024-10-15−1,674→ 15,059 total→ Common Stock (1,674 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the right to receive one share of the company's common stock.
- [F2]On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
- [F3]On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter.
Documents
Issuer
Generation Bio Co.
CIK 0001733294
Entity typeother
Related Parties
1- filerCIK 0001816836
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 4:05 PM ET
- Size
- 14.0 KB